Doyle Mittie

CIK 0001918845

Chief Medical OfficerDirector

Filings

Latest Jun 1, 2026

Issuers covered

Showing

14 of 14

Page 1

Track record

4 of 11 open-market trades scored (36% price coverage) - 7 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	4	75%	+4.2%	+16.5%	+17.9%	-34.1%
90 days	-	-	-	-	-	-
180 days	-	-	-	-	-	-
365 days	-	-	-	-	-	-

Issuers

Companies where Doyle Mittie has filed

Ticker	Issuer	Filings	Last filed
AVTX	Avalo Therapeutics, Inc.	11	Jun 1, 2026
DICE	Dice Therapeutics, Inc.	2	Aug 9, 2023
CGEM	Cullinan Oncology, Inc.	1	Aug 8, 2025

All filings

14 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Jun 1, 2026	AVTXAvalo Therapeutics, Inc.	SSale	679	$16.00	$10,864
May 26, 2026	AVTXAvalo Therapeutics, Inc.	AGrant	43,500	$0.00	$0
May 19, 2026	AVTXAvalo Therapeutics, Inc.	SSale	3,000	$18.76	$56,280
May 7, 2026	AVTXAvalo Therapeutics, Inc.	MExercise	77,905	$12.65	$985,498
Apr 8, 2026	AVTXAvalo Therapeutics, Inc.	SSale	3,970	$18.0122	$71,508
Apr 3, 2026	AVTXAvalo Therapeutics, Inc.	SSale	679	$16.00	$10,864
Mar 18, 2026	AVTXAvalo Therapeutics, Inc.	SSale	25,492	$16.1465	$411,607
Mar 2, 2026	AVTXAvalo Therapeutics, Inc.	Holdings only	-	-	-
Dec 12, 2025	AVTXAvalo Therapeutics, Inc.	FTax	1,013	$4.10	$4,153
Aug 8, 2025	CGEMCullinan Oncology, Inc.	Holdings only	-	-	-
Jan 30, 2025	AVTXAvalo Therapeutics, Inc.	Holdings only	-	-	-
Jul 16, 2024	AVTXAvalo Therapeutics, Inc.	Holdings only	-	-	-
Aug 9, 2023	DICEDice Therapeutics, Inc.	Holdings only	-	-	-
Apr 1, 2022	DICEDice Therapeutics, Inc.	Holdings only	-	-	-

Showing 1-14 of 14

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value